Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

137.87 +2.31 (+1.70%)
Official Closing Price Updated: 7:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
3 Value Stocks We Think Twice About
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
What's Going With Dialysis Firm DaVita Stock On Friday?
DaVita reported a ransomware attack affecting 2.7 million patients, posted Q2 earnings above estimates, and authorized a $2 billion boost to its share buyback plan. 
Via Benzinga
DaVita Under Fire After Cyberattack Compromises 2.7 Million Patients’ Information
The dialysis provider said care at its nearly 3,000 clinics and at-home programs continued without interruption, though the attack caused temporary disruptions and $13.5 million in added costs. 
Via Stocktwits
Topics Hacking
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
The Oracle of Omaha's investing strategies have stood the test of time. 
Via The Motley Fool
Topics Electric Vehicles Government
Earnings Scheduled For August 5, 2025
 
Via Benzinga
1 Oversold Stock Primed to Rebound and 2 We Brush Off
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling... 
Via StockStory
Buffett Reveals UnitedHealth Stake, Trims Apple In Berkshire Hathaway Q2 13F Filing
A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake in UnitedHealth. 
Via Benzinga
DVA Q2 Deep Dive: Cyber Incident Drives Volume Headwinds as Cost Controls Support Outlook
Via StockStory
Berkshire Hathaway 13F Preview: Did Buffett Trim Apple—And Will The Mystery Stock Be Revealed?
Warren Buffett has requested confidentiality in a new Berkshire Hathaway position. Will investors find out the stock Thursday? 
Via Benzinga
3 Small-Cap Stocks with Warning Signs
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
3 No-Brainer Warren Buffett Stocks to Buy Right Now
The Oracle of Omaha's approach to picking stocks still works as well as it ever has. 
Via The Motley Fool
Topics Credit Cards
Why DaVita (DVA) Stock Is Nosediving
Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 8.5% in the afternoon session after the company reported a decline in patient treatment volumes and lowered its full-year forecast for the key... 
Via StockStory
Topics Artificial Intelligence
Which S&P500 stocks are moving on Wednesday?
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Wednesday.
Pre-market stock analysis of S&P500 stocks on 2025-08-06: top gainers and losers in today's session. 
Via Chartmill
DaVita’s (NYSE:DVA) Q2 Sales Beat Estimates
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2025, with sales up 6.1% year on year to $3.38 billion. Its non-GAAP profit of $2.95 per share was 7.3% above... 
Via StockStory
Topics Earnings
DaVita Inc (NYSE:DVA) Reports Mixed Q2 2025 Earnings with EPS Beat and Slight Revenue Miss
DaVita Inc (NYSE:DVA) reported mixed Q2 2025 earnings, with revenue slightly missing estimates at $3.38B but EPS beating at $2.95. Stock rose modestly post-release. 
Via Chartmill
Warren Buffett Just Bought Even More of This Dirt-Cheap Stock
Berkshire Hathaway now owns 37% of this company. 
Via The Motley Fool
Topics Regulatory Compliance
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings
Berkshire Hathaway sold 1.64 million shares of DaVita Inc. for $230 million just before DaVita's Q2 earnings. 
Via Benzinga
Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings
Analysts expect a strong Q2 for DaVita, with projected year-over-year growth in revenue, EBITDA, and earnings. 
Via Stocktwits
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what to look for. 
Via StockStory
Topics World Trade
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Wednesday's session: top gainers and losers in the S&P500 index
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug. 
Via Investor's Business Daily
Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
1 Profitable Stock Worth Your Attention and 2 to Approach with Caution
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
DVA Q1 Earnings Call: Cyber Incident, Volume Decline, and Policy Updates Shape Outlook
Dialysis provider DaVita Inc. (NYSE:DVA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 5% year on year to $3.22 billion. Its non-GAAP EPS of $2 per share was 1% below... 
Via StockStory
3 Value Stocks with Questionable Fundamentals
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Topics Economy
3 S&P 500 Stocks Walking a Fine Line
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Economy Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.